Bisfuranoid mycotoxins: their genotoxicity and carcinogenicity

Area of Science:

• Toxicology
• Molecular Biology
• Carcinogenesis

Background:

• Aflatoxin B1 (AFB1) is a bisfuranoid mycotoxin with known toxic effects.
• Understanding the molecular mechanisms of AFB1 toxicity and carcinogenicity is crucial for public health.

Purpose of the Study:

• To elucidate the mode of toxic action of AFB1.
• To investigate the utility of AFB1-DNA and AFB1-albumin adducts in molecular dosimetry.
• To explore the correlation between AFB1-DNA adducts and carcinogenicity.
• To provide evidence supporting AFB1's role in human liver cancer.

Main Methods:

• Analysis of AFB1's mode of action and its biologically active intermediates.
• In vivo studies to detect and quantify DNA and plasma albumin adducts.
• Correlation analysis between adduct levels and carcinogenicity data.
• Detection of AFB1-DNA adducts in liver cancer patients.

Main Results:

• AFB1 toxicity stems from epoxidation of its dihydrobisfuran functionality.
• In vivo DNA and albumin adducts serve as biomarkers for exposure to AFB1.
• A linear correlation exists between AFB1-FAPy-DNA adduct levels and AFB1 carcinogenicity.
• AFB1-DNA adducts were consistently found in the livers of patients with primary liver cancer.

Conclusions:

• The epoxidation of AFB1 is the primary mechanism of its toxic action.
• Molecular dosimetry using AFB1 adducts is a viable approach for assessing exposure.
• The correlation between AFB1-DNA adducts and carcinogenicity provides insights into cancer mechanisms.
• AFB1 is confirmed as a significant etiological factor in human primary liver cancer, supporting IARC classifications.